Alumis (ALMS) Price to Book (2024 - 2026)
Alumis' (ALMS) quarterly Price to Book came in at 7.74 in Q2 2026, up 1536.54% year-over-year from 0.47 in Q2 2025, and up 141.3% quarter-over-quarter from 3.21 in Q4 2025.
Analysis
Alumis (ALMS) Price to Book (2024 - 2026) Analysis & Trends
Alumis (ALMS) has reported Price to Book for 3 consecutive years, with 7.74 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Book rose 1536.54% year-over-year to 7.74 in Q2 2026; TTM through Jun 2026 was 7.74, a 1536.54% increase from a year earlier, with the FY2025 full-year figure at 3.21, up 271.64% from the prior year.
- Price to Book was 7.74 for Q2 2026 at Alumis, up from 3.21 in the prior quarter.
- Over five years, Price to Book peaked at 7.74 in Q2 2026 and troughed at 0.27 in Q2 2024.
- A 3-year average of 2.09 and a median of 1.23 in 2024 frame the typical range for Price to Book.
- Across the five-year window, Price to Book sank 30.39% in 2025 and jumped 1536.54% in 2026, its largest moves.
- Over 3 years, Price to Book stood at 0.86 in 2024, then soared by 271.64% to 3.21 in 2025, then jumped by 141.3% to 7.74 in 2026.
- The last three Price to Book figures came in at 7.74 (Q2 2026), 3.21 (Q4 2025), and 1.01 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | Alumis | 966.94 Mn | 464.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.74 |
| Dec 31, 2025 | 3.21 |
| Sep 30, 2025 | 1.01 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 1.72 |
| Dec 31, 2024 | 0.86 |
| Sep 30, 2024 | 1.45 |
| Jun 30, 2024 | 0.27 |